What are the factors driving the allergy diagnostics market?

The market is driven by rising incidence of conditions such as allergic rhinitis, asthma, atopic dermatitis, and food allergies, which are becoming more common due to environmental pollution, urbanization, and lifestyle changes.

Who are the key players in allergy diagnostics market?

Some key players operating in the allergy diagnostics market include Thermo Fisher Scientific, Inc.; HYCOR Biomedical; EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer, Inc.); Omega Diagnostics Group PLC; Lincoln Diagnostics, Inc.; AESKU.GROUP GmbH; Minaris Medical America, Inc.; HOB Biotech Group Corp., Ltd.; DASIT Group SPA; R-Biopharm AG; bioMérieux; Siemens Healthcare GmbH.

How big is the allergy diagnostics market?

The global allergy diagnostics market size was estimated at USD 7.09 billion in 2025 and is expected to reach USD 7.74 billion in 2026.

What is the allergy diagnostics market growth?

The global allergy diagnostics market is expected to grow at a compound annual growth rate of 11.29% from 2026 to 2033 to reach USD 16.37 billion by 2033.

Which segment accounted for the largest allergy diagnostics market share?

North America dominated the allergy diagnostics market and accounted for a 36.62% share in 2025, The increasing prevalence of food allergies, coupled with high awareness among patients and clinicians, drives demand for innovative diagnostic solutions